Endocrine profile of the pituitary-gonadal axis in female patients before and after busulfan conditioning and beti-cel infusion
| . | Before busulfan conditioning and beti-cel infusion . | After busulfan conditioning and beti-cel infusion . | ||||
|---|---|---|---|---|---|---|
| Patient 4 . | Patient 5 . | Patient 7 . | Patient 4 . | Patient 5 . | Patient 7 . | |
| LH, U/L (normal, 0.60-13.72) | 5.1 | 4.47 | 10.99 | 15.6 | 39.6 | 6.18 |
| FSH, U/L (normal, 0.97-11.60) | 3.3 | 6.47 | 13.87 | n.a. | 95.8 | 42.58 |
| Estradiol, pg/mL (normal, 40-250) | n.a. | n.a. | 12.6∗ | 18.6 | <11.8 | <11.8∗ |
| AMH, ng/mL (normal, 1.2-9.5) | 3.31 | n.a. | 0.03 | <0.02 | 0.01 | 0.01 |
| . | Before busulfan conditioning and beti-cel infusion . | After busulfan conditioning and beti-cel infusion . | ||||
|---|---|---|---|---|---|---|
| Patient 4 . | Patient 5 . | Patient 7 . | Patient 4 . | Patient 5 . | Patient 7 . | |
| LH, U/L (normal, 0.60-13.72) | 5.1 | 4.47 | 10.99 | 15.6 | 39.6 | 6.18 |
| FSH, U/L (normal, 0.97-11.60) | 3.3 | 6.47 | 13.87 | n.a. | 95.8 | 42.58 |
| Estradiol, pg/mL (normal, 40-250) | n.a. | n.a. | 12.6∗ | 18.6 | <11.8 | <11.8∗ |
| AMH, ng/mL (normal, 1.2-9.5) | 3.31 | n.a. | 0.03 | <0.02 | 0.01 | 0.01 |
AMH, anti–Müllerian hormone; FSH, follicle-stimulating hormone; LH, luteinizing hormone; n.a., not available.
Receiving hormonal contraception.